Economic burden of chronic bronchitis in the United States: A retrospective case-control study

International Journal of COPD

Volumn 6, Issue 1, 2011, Pages 73-81

  Blanchette, Christopher M ^a   Roberts, Melissa H ^a   Petersen, Hans ^a   Dalal, Anand A ^b   Mapel, Douglas W ^c  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b GLAXOSMITHKLINE   (United States)

^c LOVELACE CLINIC FOUNDATION   (United States)

Author keywords

Burden; Chronic bronchitis; Chronic obstructive pulmonary disease; Economic

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CHRONIC BRONCHITIS; CONTROLLED STUDY; DELAYED DIAGNOSIS; EMERGENCY CARE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; RETROSPECTIVE STUDY; UNITED STATES;

AGED; AMBULATORY CARE; BRONCHITIS, CHRONIC; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DRUG COSTS; EARLY DIAGNOSIS; EMERGENCY MEDICAL SERVICES; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMIC; PROPENSITY SCORE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 79251518939     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S15882     Document Type: Article

References (30)

1. Niewoehner D. Structure-function relationships: the pathophysiology of airflow obstruction. In: Stockley R, Rennard S, Rabe K, Celli B, editors. Chronic Obstructive Pulmonary Disease. Malden, MA: Blackwell Publishing Ltd; 2007.
2. Pleis J, Lucas J, Ward B. Summary health statistics for US adults: National Health Interview Survey, 2008. Vital Health Stat. 2009; 10(242):1-167.
3. Wilson L, Devine E, So K. Direct medical care costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema. Respir Med. 2000;94(3):204-213.
4. Halpern M, Higashi M, Bakst A, Schmier J. The economic impact of acute exacerbations of chronic bronchitis in the United States and Canada: a literature review. J Manag Care Pharm. 2003;9(4):353-359.
5. Belfer M, Reardon J. Improving exercise tolerance and quality of life in patients with chronic obstructive pulmonary disease. J Am Osteopath Assoc. 2009;109(5):268-278.
6. Blanchette C, Broder M, Ory C, Chang E, Dalal A. Cost and utilization of COPD and asthma among insured adults in the US. Curr Med Res Opin. 2009;25(6):1385-1392.
7. Coventry P. Does pulmonary rehabilitation reduce anxiety and depression in chronic obstructive pulmonary disease? Curr Opin Pulm Med. 2009;15(2):143-149.
8. Habraken J, ter Riet G, Gore J, Greenstone M. Health-related quality of life in end-stage COPD and lung cancer patients. J Pain Symptom Manage. 2009;37(6):973-981.
9. Halpern M, Stanford R, Borker R. The burden of COPD in the USA: results from the Confronting COPD survey. Respir Med. 2003;97(Suppl C):S81-S89.
10. Hernandez P, Balter M, Bourbeau J, Hodder R. Living with chronic obstructive pulmonary disease: a survey of patients' knowledge and attitudes. Respir Med. 2009;103(7):1004-1012.
11. Izquierdo J, Barcina C, Jimenez J, Munoz M, Leal M. Study of the burden on patients with chronic obstructive pulmonary disease. Int J Clin Pract. 2009;63(1):87-97.
12. Omachi T, Katz P, Yelin E, Gergorich S. Depression and health-related quality of life in chronic obstructive pulmonary disease. Am J Med. 2009;122(8):778-793.
13. Rodriguez Gonzalez-Moro J, de Lucas Ramos P, Izquierdo J, Lopez-Muniz Ballesteros B. Impact of COPD on physical disability and daily living activities: EDIP-EPOC I and EDIP-EPOC II studies. Int J Clin Pract. 2009;63(5):742-750.
14. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease; 2009. www.goldcopd.com/Guidelineitem.asp?1=2&2=1&intId=2003. Accessed 2010 February 16.
15. American Lung Association. Understanding chronic bronchitis. 2010. Available from http://www.lungusa.org/lung-disease/bronchitischronic/understanding-chronic-bronchitis. Accessed 2010 Feb 16.
16. Tinkelman D, Price D, Nordyke R, Halbert R. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma. 2006;43(1):75-80.
17. Akazawa M, Halpern R, Riedel A, Stanford R, Dalal A, Blanchette C. Economic burden prior to COPD diagnosis: a matched case-control study in the United States Respir Med. 2008;102:1744-1752.
18. Mapel D, Robinson S, Dastani H, Shah H, Phillips A, Lydick E. The direct medical costs of undiagnosed chronic obstructive pulmonary disease. Value Health. 2008;11(4):628-636.
19. Mapel D, Robinson S, Lydick E. A comparison of health-care costs in patients with chronic pulmonary disease using lightweight portable oxygen systems versus traditional compressed-oxygen systems. Respir Care. 2008;53(9):1-7.
20. D'Agostino R Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statist Med. 1998;17(19):2265-2281.
21. Parsons L. Reducing bias in a propensity score matched-pair sample using Greedy Matching techniques. 26th Annual SAS User Group International Conference. 2001:214-226.
22. Elixhauser A, Steiner C, Harris D, Coffey R. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8-27.
23. Mapel D, McMillan G, Frost F, et al. Predicting the costs of managing patients with chronic obstructive pulmonary disease. Respir Med. 2005; 99(10):1325-1333.
24. Barr R, Celli B, Mannino D, Petty T. Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med. 2009;122(4):348-355.
25. Bourbeau J, Sebaldt R, Day A, Bouchard J, Kaplan A. Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE study. Can Respir J. 2008;15:13-19.
26. Delea T, Hagiwara M, Dalal A, Stanford R, Blanchette C. Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol versus other inhaled maintenance therapies. Curr Med Res Opin. 2009;25(1):1-13.
27. Maciewicz R, Warburton D, Rennard S. Can increased understanding of the rold of lung development and aging drive new advances in chronic obstructive pulmonary disease? Proc Am Thorac Soc. 2009; 6(7):614-617.
28. Joyce G, Keeler E, Shang B, Goldman D. The lifetime burden of chronic disease among the elderly. Health Aff (Millwood). 2005;24(Suppl 2): W5R18-W5R29.
29. American Lung Association. Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality. 2010. Available from: http://www.lungusa.org/finding-cures/our-research/trend-reports/copd-trendreport.pdf. Accessed 2010 Nov 12.
30. Foster T, Miller J, Marton J, Caloyeras J, Russell M, Menzin J. Assessment of the economic burden of COPD in the US: a review and synthesis of the literature. COPD. 2006;3:211-218.